TechTalk: Improving predictions in immunotherapy treatment
Friday, January 30 at 15:30 GMT | 16:30 CET | 10:30 EST | 7:30 PST
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, providing durable and even curative responses. However, today there is no reliable way to determine which immunotherapy a cancer patient will respond to with current biomarkers lacking predictive accuracy.
Dr. Hinco J. Gierman, Chief Scientific Officer, Elephas Biosciences, will share the predictive power of the Elephas Live™ Platform. This platform utilizes fresh tumor biopsies that are cut and encapsulated to be assessed for viability, tumor content, and response to immunotherapy over time.
Attend this TechTalk, and in just 20 minutes, you will discover how live tumor cytokine profiling can improve decision making and capture data non-destructively all within 72 hours of taking the biopsy.
Key learning objectives:
- Discover how to de-risk pipeline decisions with real-time immune response data
- Optimize trial design through functional profiling and biomarker validation
- Learn how to accelerate candidate therapeutic development by identifying likely responders to your treatment earlier
Who should attend?
- Pharma and biotech executives responsible for clinical pipeline development, search and evaluation, and licensing.
- Internal pharma leaders (CSO, CMO, clinical biomarker leaders, and trial directors).
Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.
Speakers
Dr. Hinco Gierman, brings over 25 years of experience in oncology and genomics, across academia and industry to Elephas. Dr. Gierman received his PhD in oncology and genomics at the University of Amsterdam and later pursued his postdoctoral research at Stanford University focused on whole genome sequencing and bioinformatic analysis. Before being CSO at Elephas, he was the VP of Product Development at Integra Connect, helping create and advance an enterprise analytical software suite tailored for clinicians and biopharma researchers.
